Gufic BioSciences Ltd (GUFICBIO) Stock Price & News

GUFICBIO:NSE

Gufic BioSciences Ltd

₹402.00

-1.58%

(-6.45) 1D

Oct 16, 3:30:00 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Last report

Aug 17, 2026

Fiscal period

Q1 2027

- / -

Revenue / Est. (INR)

2.61B / -

Fiscal Q1 2027 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in INR

Loading Previous Earnings...

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	2.37B	2.31B	2.52B	2.61B
Cost of goods sold	1.04B	1.01B	1.23B	1.15B
Cost of revenue	1.04B	1.01B	1.23B	1.15B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	374.51M	400.89M	432.36M	418.05M
Operating expense	1.03B	1.05B	889.21M	1.07B
Total operating expenses	2.07B	2.06B	2.12B	2.22B
Operating income	300.73M	252.86M	395.66M	389.00M
Other non operating income	21.16M	7.90M	-47.39M	4.58M
EBT including unusual items	226.04M	177.20M	289.51M	300.39M
EBT excluding unusual items	226.04M	177.20M	289.55M	300.39M
Income tax expense	57.82M	52.97M	70.54M	77.27M
Effective tax rate	25.58%	29.89%	24.37%	25.72%
Other operating expenses	573.19M	573.22M	380.37M	574.07M
Net income	168.24M	124.24M	218.97M	223.13M
Net profit margin	7.10%	5.37%	8.70%	8.55%
Earnings per share	-	-	-	-
Interest and investment income	-	-	16.90M	-
Interest expense	-95.84M	-83.56M	-79.83M	-93.18M
Net interest expenses	-95.84M	-83.56M	-62.93M	-93.18M
Depreciation and amortization charges	77.73M	76.92M	76.49M	77.06M
EBITDA	378.19M	286.97M	454.81M	448.16M
Gain or loss from assets sale	-	-	-	-

Finance